Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04269109 · ClinicalTrials.gov registry record
Opioid Sparing Pain Management Strategy
A clinical trial, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- 150
- Enrollment target
NCT04269109: Completed study, sponsored by Prisma Health-Upstate.
NCT04269109 is a clinical trial that has completed, run by Prisma Health-Upstate. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04269109 has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the amount of morphine milligram equivalents consumed post operatively until discharge between the control cohort and intervention cohort.
Primary Outcome
Compare the amount of morphine milligram equivalents consumed post operatively until discharge between groups.
Interventions
- OTHER Multi-modal Opioid Sparing Pain Management Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2021-03-01 |
What the finished NCT04269109 record still lists
NCT04269109 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Multi-modal Opioid Sparing Pain Management Protocol is the first listed.
NCT04269109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04269109 about?
NCT04269109 is a clinical study titled "Opioid Sparing Pain Management Strategy". The purpose of this research study is to compare the amount of morphine milligram equivalents consumed post operatively until discharge between the control cohort and intervention cohort.
What is the current status of trial NCT04269109?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2018-09-01. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT04269109?
The interventions under investigation include: Multi-modal Opioid Sparing Pain Management Protocol (OTHER).
Who is sponsoring clinical trial NCT04269109?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI